Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11055126 | 0.86 | LTA4H (0.48) | LTA4HPPARGPPARAPPARDCA1 | |
| SCHEMBL17285697 | 0.86 | LTA4H (0.47) | LTA4HPPARGPPARAPPARDCA1 | |
| SCHEMBL17285795 | 0.86 | LTA4H (0.47) | LTA4HPPARGPPARAPPARDCA1 | |
| SCHEMBL17285700 | 0.85 | LTA4H (0.47) | LTA4HPPARGPPARAPPARDCA1 | |
| SCHEMBL23834107 | 0.83 | KLK5 (0.50) | LTA4HPPARGPPARAPPARDACE | |
| SCHEMBL25181350 | 0.83 | KLK5 (0.50) | LTA4HPPARGPPARAPPARDACE | |
| SCHEMBL20253498 | 0.82 | ALDH1A1 (0.48) | LTA4HCA1CA2ACEALDH1A1 | |
| SCHEMBL20255053 | 0.82 | LTA4H (0.51) | LTA4HPPARGPPARAPPARDACE | |
| SCHEMBL31407356 | 0.81 | ACE (0.56) | LTA4HPPARGPPARAPPARDACE | |
| SCHEMBL11053690 | 0.80 | LTA4H (0.55) | LTA4HPPARGPPARACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718782-B2 | hydroxy fatty acid glycosides; used as surfactants | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2010-05-18 | — | — | US | disclosed |
| US-7718782-B2 | hydroxy fatty acid glycosides; used as surfactants | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2010-05-18 | — | — | US | disclosed |
| US-20070027106-A1 | Charged sophorolipids and sophorolipid containing compounds | AGRICULTURE, UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF, THE | 2007-02-01 | — | — | US | disclosed |
| US-20070027106-A1 | Charged sophorolipids and sophorolipid containing compounds | AGRICULTURE, UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF, THE | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027106-A1 | Charged sophorolipids and sophorolipid containing compounds | C9, CFH, C1S | LTA4H 178/4885PPARG 3477/4885PPARA 4031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.